Timeline
2015
1ªs Certificações
Primeiras certificações GMP e GDP suíça e
europeia, para os extratos de Cannabis,
incluindo o CBD.
2016
Validação de Métodos e Processos
2017
CPhI
Apresentação do óleo CBD Isolado, durante
o maior evento farmacêutico mundial, a CPhI,
em Frankfurt, Alemanha.
2017
Pipeline do TCH
Autorização da SWISSMedic para
desenvolvimento de extratos à base de
Cannabis, ricos em THC.
2019
Promediol® CBD
Promediol® CBD é lançado
na Europa e na Suíça.
2020
Promediol® CBD FULL Spectrum
Promediol® CBD FULL Spectrum é lançado
na Suíça e no Brasil.
ANNOUCEMENTS
PROMEDIOL DO BRASIL announces the licensing of the product CANNABIS SATIVA PROMEDIOL
EXTRACT – 50mg/mL, 10 mL and 30mL bottles, our first product authorized by ANVISA, for the
national pharmaceutical company BIOLAB SANUS.
To all who contributed to make this important achievement possible, our sincere thanks.
Adriana Schulz dos Santos
General Director on June 6, 2022
Our products are certified by Swissmedic (Swiss Agency for Therapeutic Products) and
recognized by E.M.A. (European Medicines Agency)
Good Manufacturing Practices
Good Agricultural Practices
Good Distribution Practices
Worldwide shipment
✓ International delivery
✓ Tracking service
✓ Advanced logistic
✓ Climatized temperature
✓ Electronic monitoring
Totally monitored, from order to delivery.
